全文获取类型
收费全文 | 15628篇 |
免费 | 1364篇 |
国内免费 | 355篇 |
专业分类
耳鼻咽喉 | 1074篇 |
儿科学 | 546篇 |
妇产科学 | 111篇 |
基础医学 | 2994篇 |
口腔科学 | 475篇 |
临床医学 | 1571篇 |
内科学 | 2574篇 |
皮肤病学 | 28篇 |
神经病学 | 3336篇 |
特种医学 | 198篇 |
外科学 | 554篇 |
综合类 | 1655篇 |
现状与发展 | 1篇 |
预防医学 | 863篇 |
眼科学 | 101篇 |
药学 | 800篇 |
5篇 | |
中国医学 | 350篇 |
肿瘤学 | 111篇 |
出版年
2024年 | 56篇 |
2023年 | 384篇 |
2022年 | 563篇 |
2021年 | 965篇 |
2020年 | 972篇 |
2019年 | 738篇 |
2018年 | 659篇 |
2017年 | 755篇 |
2016年 | 680篇 |
2015年 | 586篇 |
2014年 | 956篇 |
2013年 | 1026篇 |
2012年 | 770篇 |
2011年 | 770篇 |
2010年 | 730篇 |
2009年 | 788篇 |
2008年 | 767篇 |
2007年 | 673篇 |
2006年 | 547篇 |
2005年 | 481篇 |
2004年 | 401篇 |
2003年 | 350篇 |
2002年 | 313篇 |
2001年 | 255篇 |
2000年 | 244篇 |
1999年 | 228篇 |
1998年 | 198篇 |
1997年 | 137篇 |
1996年 | 97篇 |
1995年 | 121篇 |
1994年 | 84篇 |
1993年 | 104篇 |
1992年 | 99篇 |
1991年 | 43篇 |
1990年 | 43篇 |
1989年 | 46篇 |
1988年 | 39篇 |
1987年 | 40篇 |
1986年 | 42篇 |
1985年 | 67篇 |
1984年 | 73篇 |
1983年 | 59篇 |
1982年 | 73篇 |
1981年 | 57篇 |
1980年 | 62篇 |
1979年 | 45篇 |
1978年 | 45篇 |
1977年 | 27篇 |
1976年 | 17篇 |
1975年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
31.
The case report describes a distinct variant of non-REM (Rapid Eye Movement) arousal parasomnia, sleepwalking type, featuring repetitive abrupt arousals, mostly from slow-wave sleep, and various automatisms and semi-purposeful behaviours. The frequency of events and distribution throughout the night presented as a continuous status of parasomnia (' status parasomnicus '). The patient responded well to treatment typically administered for adult NREM parasomnias, and after careful review of the clinical presentation, objective findings and treatment outcome, sleep-related epilepsy was ruled out in favour of parasomnia. 相似文献
32.
Thellea K. Leveque Le Yu David C. Musch Ronald D. Chervin David N. Zacks 《Sleep & breathing》2007,11(4):253-257
Patients with obstructive sleep apnea (OSA), in comparison to controls, have increased levels of circulating epinephrine and
norepinephrine, both of which are risk factors for the development of central serous chorioretinopathy (CSCR). The aim of
this pilot study was to investigate the frequency of symptoms that suggest OSA in CSCR patients and normal controls. The Berlin
Questionnaire, a validated research tool to assess risk for OSA, was administered to 29 patients who met the criteria for
active, acute, non-steroid-induced CSCR and 29 controls matched for age and sex. In this retrospective case-controlled study,
the main outcome measure was increased risk for OSA. The mean age of the patients was 47.8 years (range 29–72) and the mean
age of controls was 47.3 years (range 25–70). Seventy-six percent (22) of both groups were men. Survey scores showed 58.6%
(17) of patients with CSCR to be at an increased risk for OSA compared to 31.0% (nine) of controls. A conditional logistic
regression analysis showed that the CSCR group had a higher proportion with an increased risk for OSA compared to the control
group (odds ratio=3.67; 95% CI: 1.02, 13.14; P = 0.046). Patients with CSCR may be more likely than other adults to have OSA, and screening for this sleep disorder should
be considered in this population. Further research is warranted to determine whether sleep apnea may contribute to the development
of CSCR, and to assess whether treatment of sleep apnea might offer a new therapeutic option for some patients with CSCR. 相似文献
33.
阻塞性睡眠呼吸暂停综合征的临床研究 总被引:4,自引:0,他引:4
强调对阻塞性睡眠呼吸暂停综合征的认识,以达到对该病的早期诊与治疗。方法应用Autoset诊疗系统及鼻持续正压通气治疗仪,对66例OSAS患者进行确诊及序贯治疗。 相似文献
34.
M. HÄRMÄ S. SUVANTO S. POPKIN K. PULLI M. MULDER & K. HIRVONEN 《Journal of sleep research》1998,7(3):167-174
The apparent connection between sleep debt, performance decrements and workplace accidents has generated a need for feasible vigilance tests that focus on the quantification of daytime sleepiness in occupational settings. The objective of this study was to evaluate the sensitivity of the Maintenance of Wakefulness Test (MWT) to acute sleep deprivation of various doses. Eight healthy female volunteers, mean age 28.9 years (range 23–36), participated in this laboratory study. After an adaptation night, the subjects were assigned to four counterbalanced, randomly ordered night sleep conditions. These four conditions allowed for a time in bed (TIB) of 0, 2, 4 or 8 h, producing a total sleep time of 0, 113, 218 and 427 min, respectively. The ability to sustain wakefulness was measured after the TIB period at 11.00 and 17.00 hours by the MWT. Analysis of variance with repeated measures was used to study the dependence of MWT sleep latencies on the immediately prior TIB period. Both the latency of stage 1 sleep onset and the appearance of slow eye movements reduced significantly with increased sleep loss. The quantitative relationship between the previous total sleep time and the subsequent MWT sleep latencies followed an exponentially decaying function showing a high sensitivity to acute, severe night sleep loss but low sensitivity to less severe sleep restrictions. It is concluded that the MWT seems to be a sensitive method for the estimation of acute sleep deprivation. The test results appear, however, non-linearly related to the earlier sleep debt. 相似文献
35.
Heart rate variability and apnea during sleep in Down's syndrome 总被引:1,自引:1,他引:0
RAFFAELE FERRI LILIA CURZI-DASCALOVA STEFANO DEL GRACCO MAURIZIO ELIA SEBASTIANO MUSUMECI & SALVATORE PETTINATO 《Journal of sleep research》1998,7(4):282-287
Autonomic system dysfunction has been reported to occur frequently in patients with Down's syndrome (DS) and is constituted mainly by an imbalance between the sympathetic and vagal systems. The analysis of heart rate variability (HRV) during sleep is a quantitative reliable method for studying such a mechanism, but it has not yet been extensively and adequately applied in DS. In this study, HRV during sleep was evaluated in seven DS patients and in six normal controls, by also controlling for the presence of sleep apnea or arousal. The main results were an increased sympathetic function (low-frequency component of HRV) and a decreased vagal activity (high-frequency component of HRV) in DS with respect to normal controls, during apnea-free periods. Moreover, the presence of apnea, in DS, induced a further significant increase in low-frequency and very low-frequency components of HRV during sleep Stage 2. This study provides additional evidence of a brainstem dysfunctioning in DS, responsible for the abnormal imbalance between the sympathetic and vagal systems and confirms the brainstem involvement already suggested in the literature in order to explain brainstem-auditory evoked potential abnormalities and central sleep apnea in these patients. 相似文献
36.
Torrens House provides a short residential programme for families with a baby (8–12 months of age) identified by parents as having a sleep problem such as waking frequently at night and being difficult to settle. The programme involves the promotion of infant self-settling by the use of a controlled crying technique, together with wrapping, cessation of night feeds and establishment of a day-time routine. Twenty families (with 23 babies) were followed through the programme and for 3 months afterwards. There were significant decreases in the number of times the babies woke, the number of night-feeds and the length of time awake at night at 1 month follow-up, with a reduction in depressive symptomatology of the parents and a perceived improvement in their infants' behaviour. Twenty of the 23 babies were sleeping well at 3 month follow-up. 相似文献
37.
Hans Brunner Thomas C Wetter Birgit Hogl Alexander Yassouridis Claudia Trenkwalder Elisabeth Friess 《Movement disorders》2002,17(5):928-933
We investigated non-rapid eye movement (non-REM) sleep in patients with newly diagnosed Parkinson's disease (PD) who had never previously received dopaminergic medication. There were no significant differences in the conventional sleep parameters between de novo patients with PD and a healthy control group, but the length of stage 1 sleep and the number of awakenings increased significantly upon administration of dopaminergic drugs. Analyzing the quantitative electroencephalogram (EEG), we observed a significant reduction in the low-delta frequency range and a nonsignificant increase in the sigma frequency range in de novo patients with PD. The dopaminergic medication also nonsignificantly reduced the low-delta and sigma frequencies, the latter to the level of the controls. Possible mechanisms that may account for the observed differences are discussed. It is suggested that Parkinson's disease as well as the application of dopaminergic drugs exerts a desynchronizing effect on the sleep EEG that is reflected in a disruption of sleep continuity. 相似文献
38.
Kelvin L Chou Maria L Moro-De-Casillas Melissa M Amick Leora L Borek Joseph H Friedman 《Movement disorders》2007,22(3):411-414
We examined the relationship between testosterone levels, violent dreams, and REM sleep behavior disorder (RBD) in 31 men with Parkinson's disease (PD): 12 with clinical RBD and 19 without. All PD patients with clinical RBD experienced violent dreams, but none of the 19 non-RBD patients reported violent dreams. While dream content appears to be more aggressive in PD patients with clinical RBD, the presence of violent dreams or clinical RBD is not associated with testosterone levels in men with PD. 相似文献
39.
综述了老年人睡眠质量及其影响因素、睡眠障碍的危害、老年病人睡眠的护理干预。建议进行前瞻性干预试验,为改善老年人的睡眠质量提供依据。 相似文献
40.
J. E NAGTEGAAL G. A KERKHOF M. G SMITS SWART & Y. G VAN DER MEER 《Journal of sleep research》1998,7(2):135-143
In a double-blind placebo-controlled cross-over study, 30 patients with Delayed Sleep Phase Syndrome (DSPS) were included, of whom 25 finished the study. Melatonin 5 mg was administered during two weeks in a double-blind setting and two weeks in an open setting successively or interrupted by two weeks of placebo. The study's impact was assessed by measurements of the 24-h curves of endogenous melatonin production and rectal temperature (n=14), polysomnography (n=22), actigraphy (n=13), sleep log (n=22), and subjective sleep quality (n=25). Mean dim light melatonin onset (DLMO) (±SD), before treatment, occurred at 23.17 hours (±138 min). Melatonin was administered five hours before the individual DLMO. After treatment, the onset of the nocturnal melatonin profile was significantly advanced by approximately 1.5 hour. Body temperature trough did not advance significantly. During melatonin use, actigraphy showed a significant advance of sleep onset and polysomnography, a significant decreased sleep latency. Sleep architecture was not influenced. During melatonin treatment patients felt significantly more refreshed in the morning. These results show that analysis of DLMO of patients suffering from DSPS is important both for diagnosis and therapy. These results are discussed in terms of the biochemistry of the pineal. 相似文献